环球中医药
環毬中醫藥
배구중의약
GLOBAL TCM
2014年
6期
437-440
,共4页
许卫华%王微%吕冉%符思
許衛華%王微%呂冉%符思
허위화%왕미%려염%부사
加味三香汤%功能性消化不良%肝郁脾虚证
加味三香湯%功能性消化不良%肝鬱脾虛證
가미삼향탕%공능성소화불량%간욱비허증
Jiawei Sanxiang Decoction%Functional dyspepsia%Liver stagnancy and spleen de-ficiency type
目的:观察中药加味三香汤治疗肝郁脾虚型功能性消化不良的临床疗效以及对焦虑、抑郁状态的影响。方法本研究采用随机、对照方法研究,共收集81例患者,随机分为治疗组与对照组。治疗组给予中药加味三香汤治疗,对照组给予西药复方消化酶治疗,疗程28天,对患者治疗前后的症状积分、Zung焦虑自评量表( self-rating anxiety scale, SAS)、抑郁自评量表( self-rating de-pression scale, SDS)积分进行统计分析。结果14天有效率治疗组与对照组无显著性差异(66.7%与64.0%,P>0.05);28天有效率治疗组显著高于对照组(88.2%与68.0%,P<0.05);治疗组与对照组治疗28天后症状积分较治疗前均显著减少( P<0.05),治疗前后症状积分、餐后饱胀积分、早饱积分下降程度治疗组与对照组比较有显著性差异( P<0.05)。焦虑、抑郁评分方面:治疗组治疗28天后SAS、SDS积分较治疗前均显著下降( P<0.05);治疗组SAS、SDS积分下降程度显著高于对照组(P<0.05)。安全性评价两组均无严重不良反应。结论加味三香汤治疗肝郁脾虚型功能性消化不良具有良好的疗效及安全性,并可改善患者焦虑、抑郁状态。
目的:觀察中藥加味三香湯治療肝鬱脾虛型功能性消化不良的臨床療效以及對焦慮、抑鬱狀態的影響。方法本研究採用隨機、對照方法研究,共收集81例患者,隨機分為治療組與對照組。治療組給予中藥加味三香湯治療,對照組給予西藥複方消化酶治療,療程28天,對患者治療前後的癥狀積分、Zung焦慮自評量錶( self-rating anxiety scale, SAS)、抑鬱自評量錶( self-rating de-pression scale, SDS)積分進行統計分析。結果14天有效率治療組與對照組無顯著性差異(66.7%與64.0%,P>0.05);28天有效率治療組顯著高于對照組(88.2%與68.0%,P<0.05);治療組與對照組治療28天後癥狀積分較治療前均顯著減少( P<0.05),治療前後癥狀積分、餐後飽脹積分、早飽積分下降程度治療組與對照組比較有顯著性差異( P<0.05)。焦慮、抑鬱評分方麵:治療組治療28天後SAS、SDS積分較治療前均顯著下降( P<0.05);治療組SAS、SDS積分下降程度顯著高于對照組(P<0.05)。安全性評價兩組均無嚴重不良反應。結論加味三香湯治療肝鬱脾虛型功能性消化不良具有良好的療效及安全性,併可改善患者焦慮、抑鬱狀態。
목적:관찰중약가미삼향탕치료간욱비허형공능성소화불량적림상료효이급대초필、억욱상태적영향。방법본연구채용수궤、대조방법연구,공수집81례환자,수궤분위치료조여대조조。치료조급여중약가미삼향탕치료,대조조급여서약복방소화매치료,료정28천,대환자치료전후적증상적분、Zung초필자평량표( self-rating anxiety scale, SAS)、억욱자평량표( self-rating de-pression scale, SDS)적분진행통계분석。결과14천유효솔치료조여대조조무현저성차이(66.7%여64.0%,P>0.05);28천유효솔치료조현저고우대조조(88.2%여68.0%,P<0.05);치료조여대조조치료28천후증상적분교치료전균현저감소( P<0.05),치료전후증상적분、찬후포창적분、조포적분하강정도치료조여대조조비교유현저성차이( P<0.05)。초필、억욱평분방면:치료조치료28천후SAS、SDS적분교치료전균현저하강( P<0.05);치료조SAS、SDS적분하강정도현저고우대조조(P<0.05)。안전성평개량조균무엄중불량반응。결론가미삼향탕치료간욱비허형공능성소화불량구유량호적료효급안전성,병가개선환자초필、억욱상태。
Objective To explore the efficacy of Jiawei Sanxiang Decoction and the influence on anxious and depressive state of liver stagnancy and spleen deficiency type of functional dyspepsia ( FD ) . Methods A randomized controlled trials was conducted. 81 cases of FD patients were recruited and divid-ed into treatment group and control group. Treatment group was treated with Jiawei Sanxiang Decoction, control group was treated with Compound Digestive Enzyme Capsules for 28 days. The symptom score, self-rating anxiety scale(SAS), self-rating depression scale(SDS) were analyzed before and after treatment. Results There was no significant difference between treatment group and control group ( 66. 7% vs. 64. 0%)after 14 days of treatment (P>0. 05). However, there was significant difference between treat-ment group and control group after 28 days of treatment ( 88. 2% vs 68. 0%, P <0. 05 ) . The symptom score in both groups were significantly decreased after 28 days of treatment ( P <0. 05 ) . The symptom score, postprandial fullness score, early satiety score of treatment group were significantly decreased com-pared to control group (P<0. 05) after 28 days of treatment. The SAS, SDS score were both significantly decreased in treatment group compare to baseline, the score of treatment group was significant decreased compare to control group. There was no severe side effect in both treatment group and control group. Con-clusions Jiawei Sanxiang Decoction in the treatment of liver stagnancy and spleen deficiency type of func-tional dyspepsia is safe and effective, the anxious and depressive state of FD patients can be improved.